FilingReader Intelligence
Indoco Remedies gets US approval for generic blood thinner
August 13, 2025 at 04:29 AM UTC•By FilingReader AI
Indoco Remedies received final USFDA approval for generic Rivaroxaban Tablets, equivalent to Janssen Pharmaceuticals' Xarelto used for treating venous thromboembolism.
The tablets will be available in four strengths (2.5mg, 10mg, 15mg, 20mg) and manufactured at the company's Goa facility.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:INDOCO•Bombay Stock Exchange
News Alerts
Get instant email alerts when Indoco Remedies publishes news
Free account required • Unsubscribe anytime